Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 68
Filter
1.
Chinese Medical Journal ; (24): 1478-1484, 2023.
Article in English | WPRIM | ID: wpr-980926

ABSTRACT

BACKGROUND@#Total knee arthroplasty (TKA) can reduce severe joint pain and improve functional disability in hemophilia. However, the long-term outcomes have rarely been reported in China. Therefore, this study aimed to evaluate the long-term outcomes and complications of TKA in Chinese patients with hemophilic arthropathy.@*METHODS@#We retrospectively reviewed patients with hemophilia who underwent TKA between 2003 and 2020, with at least 10 years of follow-up. The clinical results, patellar scores, patients' overall satisfaction ratings, and radiological findings were evaluated. Revision surgery for implants during the follow-up period was recorded.@*RESULTS@#Twenty-six patients with 36 TKAs were successfully followed up for an average of 12.4 years. Their Hospital for Special Surgery Knee Score improved from an average of 45.8 to 85.9. The average flexion contracture statistically significantly decreased from 18.1° to 4.2°. The range of motion (ROM) improved from 60.6° to 84.8°. All the patients accepted patelloplasty, and the patients' patellar score improved from 7.8 preoperatively to 24.9 at the last follow-up. There was no statistically significant difference in clinical outcomes between the unilateral and bilateral procedures, except for a better ROM at follow-up in the unilateral group. Mild and enduring anterior knee pain was reported in seven knees (19%). The annual bleeding event was 2.7 times/year at the last follow-up. A total of 25 patients with 35 TKAs were satisfied with the procedure (97%). Revision surgery was performed in seven knees, with 10- and 15-year prosthesis survival rates of 85.8% and 75.7%, respectively.@*CONCLUSIONS@#TKA is an effective procedure for patients with end-stage hemophilic arthropathy, which relieves pain, improves knee functions, decreases flexion contracture, and provides a high rate of satisfaction after more than ten years of follow-up.


Subject(s)
Humans , Arthroplasty, Replacement, Knee/methods , Hemophilia A/surgery , Follow-Up Studies , Retrospective Studies , Treatment Outcome , Knee Joint/surgery , Range of Motion, Articular , Arthritis/complications , Pain , Contracture/surgery , Surgeons , Knee Prosthesis
3.
Braz. j. phys. ther. (Impr.) ; 19(2): 89-96, 27/04/2015. tab
Article in English | LILACS | ID: lil-745808

ABSTRACT

BACKGROUND: The mechanism by which high-voltage electrical stimulation (HVPC) acts on edema reduction is unknown. OBJECTIVE: To assess the effect of HVPC with negative polarity (-) applied to the ankle of rats with acute joint inflammation. METHOD: Sixty-four rats were divided into four groups (n=16): inflamed+HVPC(-), 0.03 mL application of ι-carrageenan (3%) to the tibiotarsal joint plus HVPC(-); inflamed+HVPC placebo, carrageenan application and HVPC placebo; normal+HVPC(-), HVPC application(-); and normal control, no intervention. The HVPC(-) 100 Hz at a submotor level was applied daily for 45 min on three consecutive days. The variables were pain, hind-foot volume, and serum histamine and albumin assessed before and during the 48 hours following inflammation. The variables were compared using the t test, one-way ANOVA, nested ANOVA for repeated measures, and the post hoc Bonferroni test. Analysis of covariance was applied to adjust the effects of HVPC(-) by measurements of pain, inflammation, albumin, and histamine at 24 h, and the final weight was compared to the other groups. The significance level was set at p<0.05. RESULTS: There were no differences between the inflamed+HVPC(-) and inflamed+HVPC placebo groups in terms of pain or edema (p>0.05). Albumin was reduced in the groups that received the intervention, but there was no differences between them. There was only a 24 hour increase in histamine with the normal+HVPC(-) (p=0.0001) and inflamed+HVPC placebo groups (p=0.01) compared to the normal control group. CONCLUSIONS: The results of the present study suggest that HVPC(-) with the parameters employed did not reduce pain or edema and did not change serum albumin or histamine levels,, which indicates the inability of this resource to have a positive effect when treating treat acute joint inflammation. .


Subject(s)
Animals , Male , Rats , Pain/blood , Arthritis/blood , Arthritis/therapy , Serum Albumin/analysis , Histamine/blood , Electric Stimulation Therapy/methods , Edema/blood , Edema/therapy , Pain/etiology , Arthritis/complications , Random Allocation , Acute Disease , Rats, Wistar , Edema/ethnology
4.
In. Soeiro, Alexandre de Matos; Leal, Tatiana de Carvalho Andreucci Torres; Oliveira Junior, Múcio Tavares de; Kalil Filho, Roberto. Manual de condutas práticas da unidade de emergência do InCor / Manual of Clinical management of the emergency unit of InCor. São Paulo, Manole, 1; 2015. p.202-213.
Monography in Portuguese | LILACS | ID: lil-736710
5.
Rev. méd. Chile ; 142(12): 1510-1516, dic. 2014. ilus, tab
Article in Spanish | LILACS | ID: lil-734856

ABSTRACT

Background: The detection of anti-transglutaminase IgA (tTG) and anti-endomysial (EMA) is used for screening of celiac disease (CD) with a sensitivity and specificity of 90 and 99% respectively. There is an association between CD and connective tissue diseases (CTD). Aim: To report the frequency of IgA tTG and EMA in patients with a definite diagnosis of CTD and inflammatory arthropathies (IA). Material and Methods: One hundred forty nine patients, aged 19 to 86 years (133 females) with CTD and IA were studied. tTG were determined by ELISA and EMA by indirect immunofluorescence. Results: Eight participants had at least one positive antibody (5.4%, confidence intervals (CI) = 1.8-9), six had both (4.0% CI = 0.9-7.2) and two had only tTG positive. An intestinal biopsy was performed in four of these participants, finding a marked villous atrophy in three and partial atrophy in one. Conclusions: Five percent of this group of patients with CTD or IA had positive antibodies for CD.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Antibodies, Anti-Idiotypic/blood , Arthritis/complications , Celiac Disease/diagnosis , Connective Tissue Diseases/immunology , Transglutaminases/immunology , Celiac Disease/complications , Cross-Sectional Studies , Enzyme-Linked Immunosorbent Assay , Fluorescent Antibody Technique, Indirect , Immunoglobulin A/blood , Sensitivity and Specificity
6.
J. pediatr. (Rio J.) ; 90(5): 457-463, Sep-Oct/2014. tab
Article in English | LILACS | ID: lil-723166

ABSTRACT

Objective: To evaluate musculoskeletal involvement and autoantibodies in pediatric leprosy patients. Methods: 50 leprosy patients and 47 healthy children and adolescents were assessed according to musculoskeletal manifestations (arthralgia, arthritis, and myalgia), musculoskeletal pain syndromes (juvenile fibromyalgia, benign joint hypermobility syndrome, myofascial syndrome, and tendinitis), and a panel of autoantibodies and cryoglobulins. Health assessment scores and treatment were performed in leprosy patients. Results: At least one musculoskeletal manifestation was observed in 14% of leprosy patients and in none of the controls. Five leprosy patients had asymmetric polyarthritis of small hands joints. Nerve function impairment was observed in 22% of leprosy patients, type 1 leprosy reaction in 18%, and silent neuropathy in 16%. None of the patients and controls presented musculoskeletal pain syndromes, and the frequencies of all antibodies and cyoglobulins were similar in both groups (p > 0.05). Further analysis of leprosy patients demonstrated that the frequencies of nerve function impairment, type 1 leprosy reaction, and silent neuropathy were significantly observed in patients with versus without musculoskeletal manifestations (p = 0.0036, p = 0.0001, and p = 0.309, respectively), as well as multibacillary subtypes in leprosy (86% vs. 42%, p = 0.045). The median of physicians' visual analog scale (VAS), patients' VAS, pain VAS, and Childhood Health Assessment Questionnaire (CHAQ) were significantly higher in leprosy patients with musculoskeletal manifestations (p = 0.0001, p = 0.002, p = 0002, and p = 0.001, respectively). Conclusions: This was the first study to identify musculoskeletal manifestations associated with nerve dysfunction in pediatric leprosy patients. Hansen's disease should be included in the differential diagnosis of asymmetric arthritis, especially in endemic regions. .


Objetivo: Avaliar o envolvimento musculoesquelético e os autoanticorpos em pacientes pediátricos com hanseníase. Métodos: Foram avaliados 50 pacientes com hanseníase e 47 crianças e adolescentes saudáveis de acordo com manifestações musculoesqueléticas (artralgia, artrite e mialgia), síndromes dolorosas musculoesqueléticas (fibromialgia juvenil, síndrome de hipermobilidade articular benigna, síndrome miofascial e tendinite) e painel de autoanticorpos e crioglobulinas. Escores de avaliação de saúde e tratamento foram realizados nos pacientes com hanseníase. Resultados: Pelo menos uma manifestação musculoesquelética foi observada em 14% dos pacientes com hanseníase e em nenhum controle. Dentre os pacientes com hanseníase, cinco tinham poliartrite assimétrica das pequenas articulações das mãos. Comprometimento da função do nervo foi observado em 22% dos pacientes com hanseníase, reação tipo I hansênica em 18% e neuropatia silenciosa em 16%. Nenhum dos pacientes e controles apresentou síndromes de dor musculoesquelética e as frequências dos anticorpos e crioglobulinas foram semelhantes nos dois grupos (p > 0,05). Comprometimentos da função nervosa, reação hansênica tipo I e neuropatia silenciosa foram observados em pacientes com vs sem manifestações musculoesqueléticas (p = 0,0036, p = 0,0001 e p = 0,309, respectivamente), bem como subtipos de hanseníase multibacilar (86% vs 42%, p = 0,045). A escala visual analógica (EVA) do médico, dos pacientes, e da dor e o Questionário de Avaliação de Saúde Infantil foram maiores em pacientes com manifestações musculoesqueléticas (p = 0,0001, p = 0,002, p = 0002 e p = 0,001, respectivamente). Conclusão: Este foi o primeiro ...


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Male , Autoantibodies/analysis , Leprosy/complications , Musculoskeletal Diseases/etiology , Arthritis/complications , Arthritis/diagnosis , Brazil , Cross-Sectional Studies , Cryoglobulins/analysis , Fluorescent Antibody Technique, Indirect , Musculoskeletal Diseases/diagnosis , Students , Visual Analog Scale
7.
Rev. bras. reumatol ; 54(2): 83-89, Mar-Apr/2014. graf
Article in Portuguese | LILACS | ID: lil-710225

ABSTRACT

Este estudo avaliou o efeito de dois protocolos de exercício na nocicepção, edema e migração celular em ratos com artrite induzida por CFA. Ratos Wistar fêmeas (200 - 250 g, n = 50) foram induzidos à monoartrite por adjuvante completo de Freund (CFA, Mycobacterium butyricum; 0,5 mg/mL; 50 μL) na articulação do joelho direito (TF; n = 24) ou tornozelo direito (TT; n = 26). A incapacitação articular foi mensurada pelo tempo de elevação da pata (TEP; s) em 1 minuto de avaliação. O edema do joelho ou tornozelo foi avaliado pela medida do diâmetro articular (AD, cm) e pelo edema de pata (EP, mL), respectivamente. Ambos foram avaliados durante 10 dias consecutivos. Dois protocolos de exercício foram realizados: (a) exercício constante (TF, n = 6; TT, n = 6), realizando 1 minuto diário de exercício no cilindro (3 r.p.m.); (b) exercício variável (TF, n = 6; TT, n = 7), exercício com aumento de 1 minuto por dia, totalizando 10 minutos no último dia. Os grupos-controle (TF, n = 12; TT, n = 13) não realizaram exercício. Após 10 dias, os animais foram eutanasiados para contagem total (células/mm3) e diferencial (mononucleares e polimorfos nucleares; células/mm3) de leucócitos do tecido inflamado. O exercício variável inibiu a incapacitação e o edema em ambas as articulações. Entretanto, reduziu a migração total de leucócitos apenas na articulação TF. O exercício constante inibiu o edema nas duas articulações e reduziu a migração total de leucócitos da articulação TT. Porém, não reduziu a incapacitação. O exercício variável pareceu ser mais efetivo em reduzir os parâmetros inflamatórios em comparação com o exercício constante.


This study evaluated the effects of two protocols of exercise on nociception, edema and cell migration in rats with CFA-induced arthritis. Female Wistar rats (200 - 250 g, n = 50) was monoarthritis-induced by complete Freund's adjuvant (CFA; Mycobacterium butyricum, 0.5 mg/mL; 50 μL) into the right knee joint (TF; n = 24) or right ankle joint (TT; n = 26). Incapacitation was measured by the paw elevation time (TEP; s) in 1-min periods of observation. The edema of the knee or ankle joints was evaluated by the variation of the articular diameter (DA, cm) and by the paw volume variation (EP, mL), respectively. Both were measured during 10 consecutive days. Two protocols of exercise were performed: (a) in the constant exercise group (TF, n = 6; TT, n = 6) performing 1 minute of daily exercise on the cylinder; (b) variable exercise group (TF, n = 6; TT, n = 7), the exercise increased by 1 minute per day. The control groups (TF, n = 12; TT, n = 13) didn´t perform the exercise. After 10 days, the animals were euthanized for total (CT; cells/mm3) and differential leukocyte counts (mononuclear - MON, and polymorphonuclear - PMN, cells/mm3) of the articular inflammatory exudate. The variable exercise protocol inhibited incapacitation and edema for both joints. However, cell migration decreased only in the TF.The constant exercise reduced edema in both joints, and cell migration was decreased in the TT. However, the incapacitation was not reduced. Variable exercise seemed to be more effective in reducing the inflammatory parameters than constant exercise.


Subject(s)
Animals , Female , Rats , Arthralgia/etiology , Arthralgia/prevention & control , Arthritis/complications , Edema/etiology , Edema/prevention & control , Walking , Arthritis/chemically induced , Arthritis/immunology , Cell Movement , Freund's Adjuvant/administration & dosage , Leukocytes/physiology , Rats, Wistar , Time Factors
8.
Rev. Assoc. Med. Bras. (1992) ; 58(4): 489-492, July-Aug. 2012. tab
Article in English | LILACS | ID: lil-646893

ABSTRACT

OBJECTIVE: To study the prevalence of Jaccoud arthropathy (JA) in a sample of local systemic lupus erythematosus (SLE) patients and its clinical and serological associations. METHODS: 308 SLE patients from a single university center for the last two years were interviewed and examined. The presence of JA was searched for according to the JA index. After this, charts were reviewed for clinical and serological profile. RESULTS: The studied sample was composed by 94.5% females and 5.5% males with mean age of 38.08 ± 12.04 years and mean disease duration of 29.68 ± 11.63 years. A JA prevalence of 6.1% was found in this sample. There was a positive association of JA presence with arthritis complaints (p = 0.001) and a negative association with renal involvement (p = 0.028). Patients with JA had higher positivity for anti-dsDNA (p = 0.022). CONCLUSION: Despite the positive association of JA with arthritis and anti-dsDNA, there was a negative association with nephritis. This could suggest that JA patients belong with a SLE subset with a better prognosis.


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Autoantibodies/blood , Joint Diseases/epidemiology , Lupus Erythematosus, Systemic/complications , Antibodies, Antinuclear/blood , Arthritis/blood , Arthritis/complications , Biomarkers/blood , Cross-Sectional Studies , Joint Diseases/blood , Joint Diseases/complications , Lupus Erythematosus, Systemic/blood , Prevalence , Serologic Tests/statistics & numerical data
9.
Journal of Korean Medical Science ; : 96-100, 2012.
Article in English | WPRIM | ID: wpr-39059

ABSTRACT

The triad of rash, arthritis, and uveitis seems to be characteristic for early-onset childhood sarcoidosis. We describe an interesting case of early-onset childhood sarcoidosis coexisting enchondromatosis, which clinically masquerade as Langerhans cell histiocytosis. A 33 months old girl presented with skin rash, subcutaneous nodules with polyarthritis, and revealed the involvement of lymph nodes as well as spleen during work-up. She also presented with multiple osteolytic lesions which pathologically proven enchondromatosis. Oral prednisone was prescribed at 2 mg/kg/day for 2 months until when subcutaneous nodules and joint swellings almost disappeared, and then slowly tapered over a period of 5 months. We report an unusual case of early-onset childhood sarcoidosis presented with osteolytic bone lesions which were irrelevant to sarcoidosis.


Subject(s)
Child, Preschool , Female , Humans , Administration, Oral , Anti-Inflammatory Agents/therapeutic use , Arthritis/complications , Diagnosis, Differential , Enchondromatosis/complications , Exanthema/etiology , Positron Emission Tomography Computed Tomography , Prednisone/therapeutic use , Sarcoidosis/complications , Whole Body Imaging
10.
West Indian med. j ; 60(6): 688-689, Dec. 2011.
Article in English | LILACS | ID: lil-672837

ABSTRACT

Systemic lupus erythematosus (SLE) is a systemic disease characterized by arthritis among other protean manifestations. Occasionally lupus flares occur and is associated with increasing joint pains. In this state, complement is activated and leads to precipitation of immune complexes. Neisserial infections are cleared by complement and so in the presence of deficient complement, these infections will flourish. Disseminated gonococcal infection (DGI) occurs infrequently. A case of Neisseria gonorrhoea presenting as the arthritis-dermatitis syndrome which mimicked a lupus flare is presented and the appropriate literature reviewed.


Subject(s)
Adult , Female , Humans , Arthritis/immunology , Gonorrhea/immunology , Lupus Erythematosus, Systemic/immunology , Arthritis/complications , Arthritis/diagnosis , Diagnosis, Differential , Gonorrhea/complications , Gonorrhea/diagnosis , Gonorrhea/drug therapy , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/diagnosis , Neisseria gonorrhoeae/immunology , Syndrome
11.
Indian J Pediatr ; 2010 Mar; 77(3): 329-331
Article in English | IMSEAR | ID: sea-142534

ABSTRACT

Metabolic disorders are often encountered in clinical practice. Some of these diseases are associated with dermatological and musculoskeletal manifestations. Familial hypercholesterolemia is a disorder of lipoprotein metabolism characterized by elevated cholesterol, low-density lipoprotein cholesterol, xanthomas and early onset atherosclerosis. Tendinitis and arthritis have been rarely reported in patients with familial hypercholesterolemia. Here is presented a case of a young girl with migratory polyarthritis, who was diagnosed as probable homozygote familial hypercholesterolemia with hypercholesterolemic arthritis. A proper knowledge of cutaneous manifestations helps to identify patients at risk, establish the underlying diagnosis, and start early and effective therapy.


Subject(s)
Arthritis/complications , Child , Female , Humans , Hyperlipoproteinemia Type II/complications , Hyperlipoproteinemia Type II/diagnosis
12.
Rev. AMRIGS ; 53(2): 195-197, abr.-jun. 2009. ilus
Article in Portuguese | LILACS | ID: lil-522367

ABSTRACT

A sarcoidose é uma doença crônica granulomatosa, de origem desconhecida, que pode envolver praticamente qualquer órgão, mas na qual a presença de artrite é incomum. Apresentamos um caso no qual a artrite foi o achado inicial, associada ao eritema nodoso, levando à investigação e ao diagnóstico da síndrome de Lõfgren. Nessa forma de apresentação da sarcoidose, além da artrite ou artralgias e do eritema nodoso, também deve estar presente a linfadenopatia hilar bilateral como critério diagnóstico. A síndrome de Lõfgren é chamada algumas vezes de sarcoidose aguda, estando geralmente associada com um bom prognóstico e resolução espontânea.


Sarcoidosis is a chronic granulomatous disease, of unknown origin, that may involve virtually any organ, but in which the presence of arthritis is uncommon. Here we present a case in which arthritis was the first finding, associated with erythema nodosun, leading to the investigation and diagnosis of Lõfgren Syndrome. In this form of sarcoidosis presentation, in addition to arthritis or arthralgia and erythema nodosun there must be bilateral hilar lymphadenopathy as a diagnostic criterion. Lõfgren’s syndrome is sometimes called acute sarcoidosis, usually being associated with good prognosis and spontaneous resolution.


Subject(s)
Humans , Middle Aged , Arthritis/complications , Arthritis/diagnosis , Arthritis/etiology , Arthritis/physiopathology , Sarcoidosis/complications , Sarcoidosis/diagnosis , Sarcoidosis/physiopathology , Erythema Nodosum/complications , Erythema Nodosum/diagnosis , Erythema Nodosum/physiopathology
13.
Article in English | IMSEAR | ID: sea-91695

ABSTRACT

Rarely rheumatological features may dominate and is the cause of missed or delayed diagnosis of a malignant lesion. A case is presented wherein the patient with embryonal type of testicular tumour masqueraded with symmetrical polyarthritis with small joint involvement. p53 antigen was detected in testicular tissue. Such an example is indeed unreported in literature to the best of our knowledge.


Subject(s)
Adult , Arthritis/complications , Humans , Liver Neoplasms/secondary , Male , Neoplasms, Germ Cell and Embryonal/complications , Orchiectomy , Testicular Neoplasms/complications , Testis/pathology , Tumor Suppressor Protein p53
14.
Medical Journal of Cairo University [The]. 2008; 76 (3 Supp. I): 137-141
in English | IMEMR | ID: emr-101446

ABSTRACT

Articular involvement is a frequent extrahepatic manifestation of hepatitis C virus infection. The distinction between HCV-related polyarthropathy and true RA may be very difficult especially with recent onset RA before articular damage and erosions develop. To assess the diagnostic utility of anti-CCP antibodies and compare it with that of rheumatoid factor in distinguishing between rheumatoid arthritis and HCV related polyarthropathy. Anti-CCP antibodies and RF were determined in the sera of 30 patients with RA and 22 patients with HCV-related polyarthropathy. Anti-CCP antibodies were positive in 83.3% of patients with RA and in 4.5% in patients with HCV and polyarthropathy. RF was positive in 90% of RA patients and in 81.1% of HCV patients with polyarthropathy. The anti-CCP antibodies showed higher specificity for RA compared to RF [95.4% Vs 18.2%]. However the sensitivity of anti-CCP was comparable to that of RF [83.3% Vs 90%]. Anti-CCP antibodies are reliable laboratory markers to differentiate between RA and HCV-related polyarthropathy


Subject(s)
Humans , Male , Female , Arthritis/complications , Hepatitis C, Chronic , Peptides, Cyclic , Antibodies , Liver Function Tests , Blood Sedimentation , Rheumatoid Factor/blood , Biomarkers
15.
Journal of Korean Medical Science ; : 521-525, 2008.
Article in English | WPRIM | ID: wpr-201064

ABSTRACT

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome reflects a serious hypersensitivity reaction to drugs, characterized by skin rash, fever, lymph node enlargement, and internal organ involvement. So far, numerous drugs such as sulfonamides, phenobarbital, sulfasalazine, carbamazepine, and phenytoin have been reported to cause the DRESS syndrome. We report a case in a 29-yr-old female patient who had been on celecoxib and anti-tuberculosis drugs for one month to treat knee joint pain and pulmonary tuberculosis. Our patient's clinical manifestations included fever, lymphadenopathy, rash, hypereosinophilia, and visceral involvement (hepatitis and pneumonitis). During the corticosteroid administration for DRESS syndrome, swallowing difficulty with profound muscle weakness had developed. Our patient was diagnosed as DRESS syndrome with eosinophilic polymyositis by a histopathologic study. After complete resolution of all symptoms, patch tests were positive for both celecoxib and ethambutol. Although further investigations might be needed to confirm the causality, celecoxib and ethambutol can be added to the list of drugs as having the possibility of DRESS syndrome.


Subject(s)
Adult , Female , Humans , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Antitubercular Agents/adverse effects , Arthritis/complications , Drug Eruptions/etiology , Eosinophilia/chemically induced , Ethambutol/adverse effects , Myositis/chemically induced , Pyrazoles/adverse effects , Sulfonamides/adverse effects , Syndrome , Tuberculosis, Pulmonary/complications
16.
Asian Pac J Allergy Immunol ; 2006 Mar; 24(1): 57-63
Article in English | IMSEAR | ID: sea-36941

ABSTRACT

X-linked agammaglobulinemia (XLA) is a primary immunodeficiency characterized by a failure to generate immunoglobulins of all isotypes due to the absence of mature B cells and plasma cells, secondary to mutations in the Bruton's tyrosine kinase (Btk) gene. We report six patients with XLA, confirmed by mutation analysis, from northern Thailand. The mean age of onset was 2.5 years and the mean age at diagnosis was 7.3 years. All patients had a history of otitis media, pneumonia and arthritis at the time of diagnosis, five patients had developed bronchiectasis and 3 patients septicemia. Other infections reported included sinusitis (5/6), pericarditis (1/6), meningitis (1/6) and pyoderma (1/6). Haemophilus influenzae, Streptococcus pneumoniae, Pseudomonas aeruginosa and Staphylococcus aureus were isolated on multiple occasions. One patient died of sepsis at the age of 16 years. These observations demonstrate that early diagnosis and treatment can improve prognosis and quality of life.


Subject(s)
Agammaglobulinemia/complications , Age of Onset , Arthritis/complications , Bacterial Infections/complications , Child , Child, Preschool , DNA Mutational Analysis , Genetic Diseases, X-Linked/complications , Humans , Immunoglobulins, Intravenous/therapeutic use , Infant , Male , Otitis Media/complications , Pedigree , Pneumonia/complications , Thailand
17.
J Postgrad Med ; 2005 Oct-Dec; 51(4): 269-72; discussion 272-4
Article in English | IMSEAR | ID: sea-117523

ABSTRACT

BACKGROUND: Prevalence of Crohn's disease (CD) among patients with rheumatic illnesses in India is grossly under estimated, especially when it has overtaken that of Ulcerative Colitis in the West. AIM: To study the frequency of histologically unequivocal CD amongst clinically suspected patients with enteropathic arthropathy and to ascertain if the arthritics with CD have any independent clinical predictor. Settings and designs: Retrospective datasheet analysis from a Rheumatology clinic of a large tertiary care centre. MATERIALS AND METHODS: Patients of suspected enteropathic arthropathy were studied by ileocolonoscopy and segmental colonic biopsy for histological evidence of Crohn's disease and followed up. STATISTICAL ANALYSIS: Logistic regression analysis was done to find out any clinical predictor of histologically proven CD. RESULTS: Fourteen of the twenty-nine patients studied had histologically confirmed CD. Those with CD were younger than those without (34.7 yr vs 41.6 yrs, p=0.057). The CD group also had significantly higher number of people with loss of weight (12 vs 1), fever (11 vs 0), perianal fistula (4 vs 0), abdominal pain (8 vs 2), history of dysentery (4 vs 0) and uveitis (6 vs 1) (p=0.00002, 0.00001, 0.026, 0.013, 0.026 & 0.01 respectively). However logistic regression analysis of the most relevant ones among these, namely, loss of weight, fever, and perianal fistula showed loss of weight as only independent predictor of CD in this subset of patients (p=0.03 with odds ratio of 28). CONCLUSION: Presence of significant loss of weight in an Indian patient with clinically suspected enteropathic arthropathy is an independent predictor of CD.


Subject(s)
Adult , Arthritis/complications , Crohn Disease/complications , Female , Humans , India , Male , Middle Aged , Outpatient Clinics, Hospital , Retrospective Studies , Weight Loss
18.
Indian J Pediatr ; 2005 Apr; 72(4): 366; author reply 366
Article in English | IMSEAR | ID: sea-81418
19.
Jinotepe; s.n; feb. 2005. 31 p. tab.
Monography in Spanish | LILACS | ID: lil-592847

ABSTRACT

El objetivo de la presente revisión documental es para analizar el comportamiento, manejo y estrategias de la atención de la Artritis úrica como enfermedad crónica no transmisible; a la vez ampliar nuestro conocimientos científicos para brindar una atención más especializada e individualizada a estos pacientes. En el Municipio de Dolores ha tenido un incremento de 11 pacientes en el primer semestre del año 2004 en relación al año anterior ya que existia un sub registro de 6 pacientes con problemas de artritis úrica como una enfermedad del sistema musculo esquéletico. En el área de estudio el paciente con artritis urica es manejado por el personal médico y enfermería quienes brindan atencion según normas del Ministerio de Salud (MINSA) aunque no al 100 por ciento, ya que las capacitaciones no van encaminadas a disminuir los factores de riesgo como lo establece el MINSA en la normativa. El diagnóstico se hace a través de un examen de artritis monoarticular de comienzo brusco con caracteristicas inflamatorias, parte del tratamiento es que el pacientes debe tener una dieta estricta y la medicación farmacológica pueda ser oral o inyectada. Actualmente esta conformado un club de dispensarizados donce se brinda educación, promoción y prevención a cerca de la enfermedad a los pacientes...


Subject(s)
Arthritis/complications , Arthritis/diagnosis , Arthritis/etiology , Arthritis/therapy , Musculoskeletal System , Primary Health Care , Risk Factors
20.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 15(1): 53-60, jan.-fev. 2005. tab
Article in Portuguese | LILACS | ID: lil-414509

ABSTRACT

O tratamento de pacientes com febre reumática compreende três fases: a profilaxia primária ou erradicação dos estreptococos da orofaringe, o tratamento sintomático das manifestações clínicas, e a profilaxia secundária ou prevenção de novos surtos. Para a profilaxia primária, a droga de escolha é a penicilina; em pacientes alérgicos à penicilina, a primeira opção é a eritromicina. As vantagens da penicilina benzatina são enfatizadas e a utilização de outros antibióticos como as cefalosporinas e azitromicina deve ser evitada, pelo risco de desenvolvimento de resistência bacteriana. A artrite da febre reumática deve ser tratada com antiinflamatórios não-hormonais, como o ácido acetilsalicílico e o naproxeno, durante quatro a seis semanas. A cardite deve ser tratada com prednisona na dose inicial de 2 mg/kg/dia, com reduções progressivas, dependentes da evolução, até completar 12 semanas. O uso de corticosteróides por via oral ou parenteral e de gamaglobulina não interfere no prognóstico da cardite. Para o tratamento da coréia utilizam-se o haloperidol ou os valproatos. Os barbitúricos, a prednisona em altas doses e a carbamazepina apresentam eficácias comparáveis. A profilaxia secundária deve ser realizada com a penicilina benzatina e, nos casos de alergia à penicilina, com a sulfadiazina ou a eritromicina. Doses de 1.200.000 U devem ser recomendadas e administradas a cada três semanas. A profilaxia secundária deve se estender até os 18 anos ou, no mínimo, durante cinco anos em pacientes sem cardite. A presença de cardite indica a profilaxia durante a vida inteira ou pelo menos até os 25 anos e no mínimo durante dez anos.


Subject(s)
Humans , Male , Female , Arthritis/complications , Arthritis/diagnosis , Chorea/complications , Chorea/diagnosis , Rheumatic Fever/complications , Rheumatic Fever/diagnosis , Myocarditis/complications , Myocarditis/diagnosis , Endocarditis, Bacterial/complications , Endocarditis, Bacterial/diagnosis , Penicillins/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL